[1]
“GENETIC DEVELOPMENT OF CAR-T CELLS IN THE TREATMENT OF HEMATOLOGIC NEOPLASMS”, RECIMA21, vol. 5, no. 1, p. e516012, Nov. 2024, doi: 10.47820/recima21.v5i1.6012.